+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

E

Actively Recruiting

Healthy Volunteer

Researchers are evaluating the safety and tolerability of a new multivalent pneumococcal vaccine called PG4 in healthy infants. The study compares this new vaccine to the currently used 20-valent pneumococcal conjugate vaccine 20vPnC to see how well they protect against infections like pneumonia, meningitis, and ear infections caused by Streptococcus pneumoniae. The trial is a Phase 3, randomized, double-blinded study involving about 2400 infants around 2 months old. Participants will be randomly assigned to receive either the new PG4 vaccine or the 20vPnC vaccine. Both vaccines are given as injections into the left thigh muscle at 2, 4, 6, and between 12 to 15 months of age. The study lasts about 16 to 19 months, during which infants will have six clinic visits and one phone call to monitor their health and any side effects. During these visits, parents or legal guardians will report any local reactions, systemic events, or other adverse effects experienced by the infant after each vaccine dose. Researchers will track events occurring within seven days after each dose, as well as serious adverse events up to six months following the last dose. The goal is to understand the safety profile of the new vaccine compared to the existing one over the course of the study period.

Age: 42Days - 98DaysAll GendersPhase 3
78 locations
R

Actively Recruiting

Researchers are evaluating the effects of cold water hydrotherapy as an addition to standard rehabilitation in patients recovering from Post-COVID Syndrome, a condition marked by ongoing fatigue, autonomic nervous system imbalance, microcirculatory problems, and mild inflammation. The study aims to see if this hydrotherapy improves quality of life compared to standard rehabilitation alone. This randomized controlled trial is sponsored by Schn Klinik Berchtesgadener Land and focuses on functional recovery during Post-COVID rehabilitation. Participants receive either standard multimodal inpatient rehabilitation with cold water hydrotherapy sessions lasting 5 to 10 minutes twice daily during the 3-week inpatient program and once daily during a 6-month follow-up, or the same rehabilitation without hydrotherapy. The study includes a 3-week inpatient treatment period plus a 6-month follow-up to monitor lasting effects. Hydrotherapy is applied as cold water treatments designed to support autonomic regulation, improve circulation, reduce inflammation, and aid muscle recovery. During the study, participants provide baseline information including symptoms, smoking history, comorbidities, and severity of their initial COVID-19 illness. They undergo pulmonary function tests, autonomic function assessments, and blood pressure measurements. Researchers track quality of life using the Short Form-12 Health Survey and evaluate fatigue, sleep quality, autonomic function, blood pressure, work absence, heart rate variability, and symptom severity. Adherence to hydrotherapy and any adverse events are monitored throughout the intervention and follow-up, with daily well-being diaries kept. The total participation lasts about six months from baseline.

Age: 18Years +All GendersPhase Not Applicable
1 location